Gene expression analysis points to hemostasis in livers of rats cotreated with lipopolysaccharide and ranitidine.

Studies in rats have demonstrated that modest underlying inflammation can precipitate idiosyncratic-like liver injury from the histamine 2-receptor antagonist, ranitidine (RAN). Coadministration to rats of nonhepatotoxic doses of RAN and the inflammagen, bacterial lipopolysaccharide (LPS), results in hepatocellular injury. We tested the hypothesis that hepatic gene expression changes could be distinguished among vehicle-, LPS-, RAN- and LPS/RAN-treated rats before the onset of significant liver injury in the LPS/RAN-treated rats (i.e., 3 h post-treatment). Rats were treated with LPS (44 x 10(6) EU/kg, i.v.) or its vehicle, then two hours later with RAN (30 mg/kg, i.v.) or its vehicle. They were killed 3 h after RAN treatment, and liver samples were taken for evaluation of liver injury and RNA isolation. Hepatic parenchymal cell injury, as estimated by increases in serum alanine aminotransferase (ALT) activity, was not significant at this time. Hierarchal clustering of gene expression data from Affymetrix U34A rat genome array grouped animals according to treatment. Relative to treatment with vehicle alone, treatment with RAN and/or LPS altered hepatic expression of numerous genes, including ones encoding products involved in inflammation, hypoxia, and cell death. Some were enhanced synergistically by LPS/RAN cotreatment. Real-time PCR confirmed robust changes in expression of B-cell translocation gene 2, early growth response-1, and plasminogen-activator inhibitor-1 (PAI-1) in cotreated rats. The increase in PAI-1 mRNA was reflected in an increase in serum PAI-1 protein concentration in LPS/RAN-treated rats. Consistent with the antifibrinolytic activity of PAI-1, significant fibrin deposition occurred only in livers of LPS/RAN-treated rats. The results suggest the possibility that expression of PAI-1 promotes fibrin deposition in liver sinusoids of LPS/RAN-treated rats and are consistent with the development of local ischemia and consequent tissue hypoxia.

[1]  Liang Shi,et al.  Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1. , 2002, American journal of physiology. Cell physiology.

[2]  B. Copple,et al.  Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  O. Bagasra,et al.  The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. , 1997, Cytokine & growth factor reviews.

[4]  Peter Hufnagl,et al.  Plasminogen activator inhibitor 1: physiological and pathophysiological roles. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[5]  P. Hufnagl,et al.  Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression. , 2003, Blood.

[6]  S. Kunkel,et al.  Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor α , 2001 .

[7]  J. Luyendyk,et al.  Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[8]  D. Mochly‐Rosen,et al.  A Selective ε-Protein Kinase C Antagonist Inhibits Protection of Cardiac Myocytes from Hypoxia-induced Cell Death* , 1997, The Journal of Biological Chemistry.

[9]  Giuseppe Cibelli,et al.  Regulation of life and death by the zinc finger transcription factor Egr‐1 , 2002, Journal of cellular physiology.

[10]  K. Jungermann,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes , 2016 .

[11]  J. Luyendyk,et al.  Inflammation and Drug Idiosyncrasy—Is There a Connection? , 2003, Journal of Pharmacology and Experimental Therapeutics.

[12]  R. Sneed,et al.  Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide. , 2001, Toxicology and applied pharmacology.

[13]  M. Tohyama,et al.  150-kDa Oxygen-regulated Protein (ORP150) Suppresses Hypoxia-induced Apoptotic Cell Death* , 1999, The Journal of Biological Chemistry.

[14]  A. J. Gandolfi,et al.  The Involvement of Endotoxin in Halothane‐associated Liver Injury , 1984, Anesthesiology.

[15]  T. Takamura,et al.  Tumor Necrosis Factor-α and Troglitazone Regulate Plasminogen Activator Inhibitor Type 1 Production through Extracellular Signal-Regulated Kinase- and Nuclear Factor-κB-Dependent Pathways in Cultured Human Umbilical Vein Endothelial Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[16]  A. Yamataka,et al.  Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia. , 1999, Journal of pediatric surgery.

[17]  S. Bursian,et al.  Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? , 2002, The Journal of pharmacology and experimental therapeutics.

[18]  Jun O. Liu,et al.  Nur77 Activated by Hypoxia-Inducible Factor-1α Overproduces Proopiomelanocortin in von Hippel-Lindau-Mutated Renal Cell Carcinoma , 2004, Cancer Research.

[19]  K. Jungermann,et al.  Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases , 2003, Thrombosis and Haemostasis.

[20]  W. Aird,et al.  Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. , 2003, Blood.

[21]  W. Abelmann,et al.  Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. , 1993, Circulation research.

[22]  D. Mochly‐Rosen,et al.  A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. , 1997, The Journal of biological chemistry.

[23]  J. Spitzer,et al.  Alcohol consumption in rats potentiates the deleterious effect of gram-negative sepsis on hepatic hyaluronan uptake. , 1993, Alcoholism, clinical and experimental research.

[24]  B. Beutler,et al.  TLR4 as the mammalian endotoxin sensor. , 2002, Current topics in microbiology and immunology.

[25]  J. Shute,et al.  Plasminogen Activator Inhibitor-1 Supports IL-8-Mediated Neutrophil Transendothelial Migration by Inhibition of the Constitutive Shedding of Endothelial IL-8/Heparan Sulfate/Syndecan-1 Complexes1 , 2003, The Journal of Immunology.

[26]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[27]  S. Stavchansky,et al.  Effect of interleukin-1 and tumor necrosis factor- on gene expression in human endothelial cells , 2003 .

[28]  H. Jaeschke,et al.  Gene array analysis of the hepatic response to endotoxin in glutathione peroxidase-deficient mice. , 2003, Toxicology letters.

[29]  V. Marder,et al.  Overview of hemostasis , 2002 .

[30]  Takuma Hayashi,et al.  Essential Role of Human Leukocyte Antigen-encoded Proteasome Subunits in NF-κB Activation and Prevention of Tumor Necrosis Factor-α-induced Apoptosis* , 2000, The Journal of Biological Chemistry.

[31]  S. Kunkel,et al.  Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. , 1993, The American journal of physiology.

[32]  D. Essayan.  Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. , 1999, Biochemical pharmacology.

[33]  S. Jin,et al.  Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Mattes.  Annotation and cross-indexing of array elements on multiple platforms. , 2004, Environmental health perspectives.

[35]  T. Takamura,et al.  Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. , 2003, The Journal of pharmacology and experimental therapeutics.

[36]  M. Follettie,et al.  Regulation of gene expression in mouse macrophages stimulated with bacterial CpG‐DNA and lipopolysaccharide , 2002, Journal of leukocyte biology.

[37]  Liang Shi,et al.  Lipopolysaccharide stimulation of ERK1/2 increases TNF-α production via Egr-1 , 2002 .

[38]  S. Stavchansky,et al.  Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. , 2003, American journal of physiology. Cell physiology.

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .